FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220652139> ?p ?o ?g. }

• W4220652139 abstract "Abstract Endocrine therapy (ET) is an effective first-line therapy for women with estrogen receptor-positive (ER + ) breast cancers. While both ionizing radiation (RT) and ET are used for the treatment of women with ER+ breast cancer, the most effective sequencing of therapy and the effect of ET on tumor radiosensitization remains unclear. Here we sought to understand the effects of inhibiting estrogen receptor (ER) signaling in combination with RT in multiple preclinical ER+ breast cancer models. Clonogenic survival assays were performed using variable pre- and post-treatment conditions to assess radiosensitization with estradiol, estrogen deprivation, tamoxifen, fulvestrant, or AZD9496 in ER+ breast cancer cell lines. Estrogen stimulation was radioprotective (radiation enhancement ratios [rER]: 0.51–0.82). Conversely, when given one hour prior to RT, ER inhibition or estrogen depletion radiosensitized ER+ MCF-7 and T47D cells (tamoxifen rER: 1.50–1.60, fulvestrant rER: 1.76–2.81, AZD9496 rER: 1.33–1.48, estrogen depletion rER: 1.47–1.51). Combination treatment resulted in an increase in double-strand DNA (dsDNA) breaks as a result of inhibition of non-homologous end joining-mediated dsDNA break repair with no effect on homologous recombination. Treatment with tamoxifen or fulvestrant in combination with RT also increased the number of senescent cells but did not affect apoptosis or cell cycle distribution. Using an MCF-7 xenograft model, concurrent treatment with tamoxifen and RT was synergistic and resulted in a significant decrease in tumor volume and a delay in time to tumor doubling without significant toxicity. These findings provide preclinical evidence that concurrent treatment with ET and RT may be an effective radiosensitization strategy." @default.
• W4220652139 created "2022-04-03" @default.
• W4220652139 creator A5000831580 @default.
• W4220652139 creator A5005345083 @default.
• W4220652139 creator A5023855843 @default.
• W4220652139 creator A5028272560 @default.
• W4220652139 creator A5031057494 @default.
• W4220652139 creator A5036540537 @default.
• W4220652139 creator A5039903293 @default.
• W4220652139 creator A5040040343 @default.
• W4220652139 creator A5047365376 @default.
• W4220652139 creator A5049482789 @default.
• W4220652139 creator A5052071953 @default.
• W4220652139 creator A5062737544 @default.
• W4220652139 creator A5068174025 @default.
• W4220652139 creator A5069748055 @default.
• W4220652139 creator A5070842981 @default.
• W4220652139 creator A5070894504 @default.
• W4220652139 creator A5080954009 @default.
• W4220652139 creator A5083302662 @default.
• W4220652139 creator A5087941453 @default.
• W4220652139 date "2022-03-10" @default.
• W4220652139 modified "2023-10-15" @default.
• W4220652139 title "Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models" @default.
• W4220652139 cites W1482139152 @default.
• W4220652139 cites W1486963096 @default.
• W4220652139 cites W1780348968 @default.
• W4220652139 cites W1961026612 @default.
• W4220652139 cites W1984646656 @default.
• W4220652139 cites W1990757649 @default.
• W4220652139 cites W2001154278 @default.
• W4220652139 cites W2027044981 @default.
• W4220652139 cites W2035564586 @default.
• W4220652139 cites W2056099440 @default.
• W4220652139 cites W2062159705 @default.
• W4220652139 cites W2069921265 @default.
• W4220652139 cites W2071068913 @default.
• W4220652139 cites W2083814039 @default.
• W4220652139 cites W2086075884 @default.
• W4220652139 cites W2090559642 @default.
• W4220652139 cites W2101217334 @default.
• W4220652139 cites W2111277038 @default.
• W4220652139 cites W2118498123 @default.
• W4220652139 cites W2124806513 @default.
• W4220652139 cites W2130504808 @default.
• W4220652139 cites W2140978771 @default.
• W4220652139 cites W2144896165 @default.
• W4220652139 cites W2149455283 @default.
• W4220652139 cites W2151644213 @default.
• W4220652139 cites W2152717505 @default.
• W4220652139 cites W2154051017 @default.
• W4220652139 cites W2156391988 @default.
• W4220652139 cites W2170797485 @default.
• W4220652139 cites W2226378258 @default.
• W4220652139 cites W2308934048 @default.
• W4220652139 cites W2344855029 @default.
• W4220652139 cites W2405233442 @default.
• W4220652139 cites W2419302768 @default.
• W4220652139 cites W2560377998 @default.
• W4220652139 cites W2745437549 @default.
• W4220652139 cites W2770903587 @default.
• W4220652139 cites W2777085303 @default.
• W4220652139 cites W2800321821 @default.
• W4220652139 cites W2899962460 @default.
• W4220652139 cites W2911188335 @default.
• W4220652139 cites W3002387027 @default.
• W4220652139 cites W3006189910 @default.
• W4220652139 cites W3024478119 @default.
• W4220652139 cites W3032063354 @default.
• W4220652139 cites W3088982470 @default.
• W4220652139 cites W3092053732 @default.
• W4220652139 cites W3092894005 @default.
• W4220652139 cites W3094721087 @default.
• W4220652139 cites W3125893929 @default.
• W4220652139 cites W3197242394 @default.
• W4220652139 cites W4301061564 @default.
• W4220652139 doi "https://doi.org/10.1038/s41523-022-00397-y" @default.
• W4220652139 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35273179" @default.
• W4220652139 hasPublicationYear "2022" @default.
• W4220652139 type Work @default.
• W4220652139 citedByCount "4" @default.
• W4220652139 countsByYear W42206521392022 @default.
• W4220652139 countsByYear W42206521392023 @default.
• W4220652139 crossrefType "journal-article" @default.
• W4220652139 hasAuthorship W4220652139A5000831580 @default.
• W4220652139 hasAuthorship W4220652139A5005345083 @default.
• W4220652139 hasAuthorship W4220652139A5023855843 @default.
• W4220652139 hasAuthorship W4220652139A5028272560 @default.
• W4220652139 hasAuthorship W4220652139A5031057494 @default.
• W4220652139 hasAuthorship W4220652139A5036540537 @default.
• W4220652139 hasAuthorship W4220652139A5039903293 @default.
• W4220652139 hasAuthorship W4220652139A5040040343 @default.
• W4220652139 hasAuthorship W4220652139A5047365376 @default.
• W4220652139 hasAuthorship W4220652139A5049482789 @default.
• W4220652139 hasAuthorship W4220652139A5052071953 @default.
• W4220652139 hasAuthorship W4220652139A5062737544 @default.
• W4220652139 hasAuthorship W4220652139A5068174025 @default.
• W4220652139 hasAuthorship W4220652139A5069748055 @default.
• W4220652139 hasAuthorship W4220652139A5070842981 @default.
• W4220652139 hasAuthorship W4220652139A5070894504 @default.

• next